Clemastine fumarate syrup
Company: Morton Grove PharmaceuticalsApproval Status: Approved March 1998
Treatment for: allergic rhinitis
Areas: Immune System; Respiratory
General Information
Clemastine fumarate syrup 0.5 mg/5 ml, a generic version of Novartis' Tavist Syrup, has been approved for the treatment of allergic rhinitis.
Clemastine fumarate syrup Drug Information
The Clemastine Fumarate Syrup drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
